Aesthetic medicine market to triple by 2029, driven by non-surgical procedures

India is rapidly emerging as a global leader in the aesthetic medicine market, projected to grow threefold to US$ 3.02 billion by 2029. This growth is fuelled by an increasing preference for non-invasive procedures such as Botox and fillers, alongside rising disposable incomes and a more health-conscious population. The International Society of Aesthetic Plastic Surgery reported a significant global shift towards non-surgical treatments, which outnumbered surgical options in 2020. Botulinum toxin remains the most sought-after non-surgical procedure, with over 9 million treatments performed worldwide, reflecting a 26.1% increase. Following closely are hyaluronic acid treatments, totalling 4.3 million.

Women currently represent 85.7% of the consumer base. However, there has also been a notable rise in the acceptance of aesthetic procedures among men and millennials, changing the industry's demographics. India's aesthetic medicine market is currently valued at approximately US$ 1.62 billion, with a compound annual growth rate (CAGR) of 13.2%. Dr. Rashmi Shetty, an aesthetic practitioner, highlights a shift in societal perception, stating, "These procedures are no longer taboo; they positively impact self-esteem and well-being."

Disclaimer: This information has been collected through secondary research and IBEF is not responsible for any errors in the same.